Chinese Traditional and Herbal Drugs
|
2025, 56(22): 8222-8233
Scientific connotation of quality delivery, toxicity reduction and efficacy retention in Leigong processing of Psoraleae Fructus
Full
GUO Xinyu1, SHI Ye1, LI Guiying2, WEI Yingjie1,3
Affiliations
1 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China;
2 Key Laboratory of New Drug Delivery Systems of Chinese Materia Medica, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China;
3 Shandong SBOND Pharmaceutical Co., Ltd., Jinan 250200, China
doi: 10.7501/j.issn.0253-2670.2025.22.014
Outline
Objective To investigate quality delivery of core components such as coumarins, flavonoids, and bakuchiol of Buguzhi (Psoraleae Fructus) during Leigong processing and the influence on toxicity/efficacy. Methods HPLC method was used to detect the dynamic changes of coumarins, flavonoids, and bakuchiol, the core components of Psoraleae Fructus in the Leigong processing process (wine soaking, water soaking, and steaming). The safety of Psoraleae Fructus before and after Leigong processing was evaluated in zebrafish embryos/larvae (1—6 dpf, days post fertilization), organ morphology was observed, mortality was recorded, and the half lethal concentration (LC50) was calculated. The zebrafish osteoporosis model was induced with 25 μmol/L prednisolone; microscopic observation and digital imaging of zebrafish larvae of each treatment group cultured to 8 dpf were performed using alizarin red, and the bone staining area was quantitatively analyzed by image software to evaluate the anti-osteoporosis activity of the above samples. Results Chinese liquor infusion mainly contained lipophilic components such as (iso) psoralen, flavonoids, and bakuchiol, and the leaching rate was 20.91%—63.93%, while the rice wine infusion was similar to that of water infusion, which only contained a small amount of hydrophilic (iso) psoralenoside and lipophilic (iso) psoralen or neobavaisoflavone (leaching rate was 0.22%—6.15%), and then after further steaming, the content of (iso) psoralenoside was significantly reduced to 9.54%—13.71% of the raw products, while the content of (iso) psoralen increased to about 134.27%—143.13% of the raw products, indicating that glycoside was converted to aglycone. In addition, the content of 4′-O-methylbroussochalcone was significantly increased (about 247.09%—288.18% of the products before steaming), which may be converted from other flavonoids by heating. The results of zebrafish evaluation showed that the safety of Leigong products using rice wine was better than that of using Chinese liquor, and both were better than that of raw products; After processing, the concentration of fish distortion was increased, the earliest death time of fish was delayed by 2—3 d, the maximum mortality rate of fish was reduced by 45%—70%, and the LC50 value of fish increased by 3—4 times. Both Leigong products and raw products could increase the mineralized area and cumulative optical density value of zebrafish skulls. Conclusion Leigong processing (wine soaking, water soaking, and steaming) causes different dynamic changes of core components of Psoraleae Fructus, such as physical leaching of core components, bioconversion of glycoside to aglycone, and chemical modification of flavonoid methylation, and the evaluation of zebrafish shows that the Leigong processing method can reduce toxicity and save effectivity, and the content reduction of neobavaisoflavone, bavachin, and backuchiol is the key factor of toxicity attenuation.
Psoraleae Fructus
/
Leigong processing
/
quality delivery
/
zebrafish
/
toxicity
/
osteoporosis
/
neobavaisoflavone
/
bavachin
/
backuchiol
郭新宇, 石也, 李桂英, 韦英杰.
补骨脂雷公炮制过程质量传递与减毒存效科学内涵探讨.
中草药,
2025
, 56
(22)
: 8222
-8233
.
DOI: 10.7501/j.issn.0253-2670.2025.22.014
GUO Xinyu, SHI Ye, LI Guiying, WEI Yingjie.
Scientific connotation of quality delivery, toxicity reduction and efficacy retention in Leigong processing of Psoraleae Fructus[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(22)
: 8222
-8233
.
DOI: 10.7501/j.issn.0253-2670.2025.22.014
Year 2025 volume 56 Issue 22
44
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.014
- Receive Date:2025-07-22
- Online Date:2026-11-13